Pharmacy

Your Article Summary

See Latest Articles

Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome
Clinical Pharmacology & Therapeutics, 08/18/06

Rachele Berria, MD, et al. - Thiazolidinediones have gained widespread use for the treatment of type 2 diabetes mellitus and other insulin resistance states, including polycystic ovary syndrome (PCOS). In thiazolidinedione-treated patients a small reduction in hemoglobin and hematocrit levels often is observed, and this generally has been attributed to fluid retention

Today in Adverse Drug Reactions...keeping you current

Receive free subspecialty "5-minute updates" via email

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Journal of the National Cancer Institute, 12/14/09

A Holistic Approach to Androgen Deprivation Therapy: Treating the Cancer without Hurting the Patient
Urologia Internationalis, 12/14/09

Spontaneous reporting of adverse drug reactions at a department of Internal Medicine
Central European Journal of Medicine, 12/14/09

 See all of Adverse Drug Reactions

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Tadalafil for the treatment of pulmonary arterial hypertension
Expert Opinion in Pharmacotherapy, 12/14/09

Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix(R)) injections versus local anesthetic in osteoarthritis of the hip
Arthritis Research & Therapy, 12/14/09

New central targets for the treatment of obesity
British Journal of Clinical Pharmacology, 12/11/09

 See all of Other Drugs